Prenetics Global (PRE) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $18.52, -8.59% vs the prior close of $20.26.
- Volume 334.71K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PRE slides 8.6% to $18.52, a 1-month low, 3 down days in a row. Closed at $18.52, -8.59% vs the prior close of $20.26. Day range $18.08–$20.38, opened at $20.11.
PRE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PRE slides 8.6% to $18.52, a 1-month low, 3 down days in a row
- Closed at $18.52, -8.59% vs the prior close of $20.26. Day range $18.08–$20.38, opened at $20.11.
- Volume was 334.71K shares, 1.5x its 50-day average of 223.97K.
- Price is -16.8% vs its 50-day average ($22.25) and -5.0% vs its 200-day average ($19.49).
- 52-week range $11.36–$27.24; today's close sits at 45% of that range, 32.0% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — PRE dips 1.7% to $20.26
- Closed at $20.26, -1.65% vs the prior close of $20.60. Day range $20.15–$20.99, opened at $20.30.
- Volume was 93.30K shares, 0.4x its 50-day average of 223.91K — lighter than usual.
- Price is -8.9% vs its 50-day average ($22.24) and +4.0% vs its 200-day average ($19.48).
- 52-week range $11.36–$27.24; today's close sits at 56% of that range, 25.6% below the 52-week high.
Oct 14, 2026 — PRE slides 3.1% to $20.60
- Closed at $20.60, -3.15% vs the prior close of $21.27. Day range $20.40–$21.64, opened at $21.30.
- Volume was 154.50K shares, 0.7x its 50-day average of 223.73K.
- Price is -7.2% vs its 50-day average ($22.21) and +5.9% vs its 200-day average ($19.46).
- 52-week range $11.36–$27.24; today's close sits at 58% of that range, 24.4% below the 52-week high.
Oct 13, 2026 — PRE rises 0.5% to $21.27
- Closed at $21.27, +0.52% vs the prior close of $21.16. Day range $20.49–$21.52, opened at $21.16.
- Volume was 96.50K shares, 0.4x its 50-day average of 223.39K — lighter than usual.
- Price is -4.0% vs its 50-day average ($22.16) and +9.4% vs its 200-day average ($19.44).
- 52-week range $11.36–$27.24; today's close sits at 62% of that range, 21.9% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — PRE slides 3.1% to $21.16, 3 down days in a row
- Closed at $21.16, -3.11% vs the prior close of $21.84. Day range $20.70–$21.66, opened at $21.10.
- Volume was 143.50K shares, 0.6x its 50-day average of 221.37K.
- Price is -4.3% vs its 50-day average ($22.11) and +9.0% vs its 200-day average ($19.42).
- 52-week range $11.36–$27.24; today's close sits at 62% of that range, 22.3% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — PRE dips 0.7% to $21.84
- Closed at $21.84, -0.73% vs the prior close of $22.00. Day range $20.91–$22.40, opened at $22.01.
- Volume was 136.00K shares, 0.6x its 50-day average of 220.05K.
- Price is -1.0% vs its 50-day average ($22.06) and +12.6% vs its 200-day average ($19.40).
- 52-week range $11.36–$27.24; today's close sits at 66% of that range, 19.8% below the 52-week high.
Oct 8, 2026 — PRE dips 2.1% to $22.00 on 2.4x normal volume
- Closed at $22.00, -2.09% vs the prior close of $22.47. Day range $21.51–$23.15, opened at $22.24.
- Volume was 509.60K shares, 2.4x its 50-day average of 211.41K — unusually heavy trading.
- Price is -0.0% vs its 50-day average ($22.01) and +13.5% vs its 200-day average ($19.38).
- 52-week range $11.36–$27.24; today's close sits at 67% of that range, 19.2% below the 52-week high.
Oct 7, 2026 — PRE jumps 10.1% to $22.47
- Closed at $22.47, +10.15% vs the prior close of $20.40. Day range $20.35–$22.80, opened at $20.40.
- Volume was 283.40K shares, 1.4x its 50-day average of 208.12K.
- Price is +2.5% vs its 50-day average ($21.93) and +16.1% vs its 200-day average ($19.36).
- 52-week range $11.36–$27.24; today's close sits at 70% of that range, 17.5% below the 52-week high.
Oct 6, 2026 — PRE dips 2.7% to $20.40
- Closed at $20.40, -2.67% vs the prior close of $20.96. Day range $19.81–$21.17, opened at $21.17.
- Volume was 320.10K shares, 1.6x its 50-day average of 204.28K.
- Price is -6.6% vs its 50-day average ($21.84) and +5.6% vs its 200-day average ($19.33).
- 52-week range $11.36–$27.24; today's close sits at 57% of that range, 25.1% below the 52-week high.
Oct 5, 2026 — PRE jumps 3.9% to $20.96
- Closed at $20.96, +3.92% vs the prior close of $20.17. Day range $20.10–$21.36, opened at $20.64.
- Volume was 156.40K shares, 0.8x its 50-day average of 204.14K.
- Price is -3.9% vs its 50-day average ($21.81) and +8.6% vs its 200-day average ($19.30).
- 52-week range $11.36–$27.24; today's close sits at 60% of that range, 23.1% below the 52-week high.
Oct 2, 2026 — PRE slides 8.1% to $20.17, a 1-month low
- Closed at $20.17, -8.11% vs the prior close of $21.95. Day range $19.85–$22.23, opened at $22.15.
- Volume was 311.50K shares, 1.5x its 50-day average of 203.09K.
- Price is -7.3% vs its 50-day average ($21.77) and +4.6% vs its 200-day average ($19.28).
- 52-week range $11.36–$27.24; today's close sits at 55% of that range, 26.0% below the 52-week high.
PRE latest news & SEC filings
Every SEC filing by or about PRE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leogrande Hudson Blake converted options/RSUs into 2,000 shares on Oct 4, 2026; now holds 8,001
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lo Hoi Chun converted options/RSUs into 7,635 shares on Sep 30, 2026; now holds 573,648
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 26, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 18,000 shares at $21.19 (≈$381.42K) on Aug 24, 2026
- Rosin Brian J bought 18,000 shares at $21.19 (≈$381.42K) on Aug 24, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 21, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade PRE
- How much it moves: over the last 20 sessions the average daily move was 3.04% (largest 10.1%). That is a volatile stock.
- Liquidity: about 191.34K shares (≈$3.54M) trade per day on average.
- 52-week position: $18.52 vs a range of $11.36–$27.24 (45% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Brian J Rosin bought 5,100 shares on Aug 25, 2026.
- Latest filings: 6-K Oct 13, 2026; 6-K Aug 26, 2026; 6-K Aug 20, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PRE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 20.11 | 20.38 | 18.08 | 18.52 | 334.71K |
| Oct 15, 2026 | 20.30 | 20.99 | 20.15 | 20.26 | 93.30K |
| Oct 14, 2026 | 21.30 | 21.64 | 20.40 | 20.60 | 154.50K |
| Oct 13, 2026 | 21.16 | 21.52 | 20.49 | 21.27 | 96.50K |
| Oct 12, 2026 | 21.10 | 21.66 | 20.70 | 21.16 | 143.50K |
| Oct 9, 2026 | 22.01 | 22.40 | 20.91 | 21.84 | 136.00K |
| Oct 8, 2026 | 22.24 | 23.15 | 21.51 | 22.00 | 509.60K |
| Oct 7, 2026 | 20.40 | 22.80 | 20.35 | 22.47 | 283.40K |
| Oct 6, 2026 | 21.17 | 21.17 | 19.81 | 20.40 | 320.10K |
| Oct 5, 2026 | 20.64 | 21.36 | 20.10 | 20.96 | 156.40K |
| Oct 2, 2026 | 22.15 | 22.23 | 19.85 | 20.17 | 311.50K |
| Oct 1, 2026 | 23.28 | 23.60 | 21.89 | 21.95 | 89.40K |
| Sep 30, 2026 | 22.83 | 23.50 | 22.57 | 23.13 | 67.30K |
| Sep 29, 2026 | 22.98 | 23.22 | 22.69 | 22.84 | 65.90K |
| Sep 28, 2026 | 22.76 | 23.08 | 22.42 | 22.76 | 74.30K |
| Sep 25, 2026 | 22.63 | 23.68 | 22.22 | 22.97 | 136.90K |
| Sep 24, 2026 | 22.71 | 23.53 | 22.13 | 22.93 | 254.20K |
| Sep 23, 2026 | 22.95 | 23.55 | 22.35 | 22.71 | 245.80K |
| Sep 22, 2026 | 24.00 | 24.00 | 22.78 | 22.90 | 240.80K |
| Sep 21, 2026 | 24.70 | 25.01 | 23.76 | 24.34 | 112.70K |
About Prenetics Global
Prenetics Global (PRE) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in QUARRY BAY, Hong Kong. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1876431.
PRE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Yin Pan Cheng | Wholly owned by Cheng Yin Pan | Jun 16, 2026 |
| Hudson Blake Leogrande | Director | Sep 4, 2026 |
| Caroline S Levy | Director | Aug 26, 2026 |
| Darshan Ravindra Shah | Director | Mar 30, 2026 |
| David Vanderveen | Director | Jun 16, 2026 |
| Danny Sheng Wu Yeung | Chief Executive Officer | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hoi Chun Lo | Chief Financial Officer | Aug 24, 2026 |
| Brian J Rosin | CFO of IM8 (US) LLC | Aug 26, 2026 |
| Thuan Yen Tat | VP, Finance of IM8 (US) LLC | Sep 4, 2026 |
| Danny Sheng Wu Yeung | Chief Executive Officer | Aug 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 6,000 | $20.90 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 6,000 | $20.90 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 6,000 | $20.90 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
PRE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PRE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PRE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.